Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report

Abstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explo...

Full description

Bibliographic Details
Main Authors: Kevin Yauy, Anouck Schneider, Bee Ling Ng, Jean-Baptiste Gaillard, Satish Sati, Christine Coubes, Constance Wells, Magali Tournaire, Thomas Guignard, Pauline Bouret, David Geneviève, Jacques Puechberty, Franck Pellestor, Vincent Gatinois
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Medical Genomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12920-019-0558-8
id doaj-af431e66ab844436af04e46b042eb9d4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Kevin Yauy
Anouck Schneider
Bee Ling Ng
Jean-Baptiste Gaillard
Satish Sati
Christine Coubes
Constance Wells
Magali Tournaire
Thomas Guignard
Pauline Bouret
David Geneviève
Jacques Puechberty
Franck Pellestor
Vincent Gatinois
spellingShingle Kevin Yauy
Anouck Schneider
Bee Ling Ng
Jean-Baptiste Gaillard
Satish Sati
Christine Coubes
Constance Wells
Magali Tournaire
Thomas Guignard
Pauline Bouret
David Geneviève
Jacques Puechberty
Franck Pellestor
Vincent Gatinois
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
BMC Medical Genomics
Intellectual disability (ID)
Topologically associated domains (TAD)
MEF2C
author_facet Kevin Yauy
Anouck Schneider
Bee Ling Ng
Jean-Baptiste Gaillard
Satish Sati
Christine Coubes
Constance Wells
Magali Tournaire
Thomas Guignard
Pauline Bouret
David Geneviève
Jacques Puechberty
Franck Pellestor
Vincent Gatinois
author_sort Kevin Yauy
title Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
title_short Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
title_full Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
title_fullStr Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
title_full_unstemmed Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
title_sort disruption of chromatin organisation causes mef2c gene overexpression in intellectual disability: a case report
publisher BMC
series BMC Medical Genomics
issn 1755-8794
publishDate 2019-08-01
description Abstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explored by microarray, Array Painting and Sanger sequencing. No gene disruption was found but the chromosome 5 breakpoint was localized 228-kb upstream of the MEF2C gene. The predicted Topologically Associated Domains analysis shows that it contains only the MEF2C gene and a long non-coding RNA LINC01226. RNA studies looking for MEF2C gene expression revealed an overexpression of MEF2C in the lymphoblastoid cell line of the patient. Conclusions Pathogenicity of MEF2C overexpression is still unclear as only four patients with mild intellectual deficiency carrying 5q14.3 microduplications containing MEF2C are described in the literature. The microduplications in these individuals also contain other genes expressed in the brain. The patient presented the same phenotype as 5q14.3 microduplication patients. We report the first case of a balanced translocation leading to an overexpression of MEF2C similar to a functional duplication.
topic Intellectual disability (ID)
Topologically associated domains (TAD)
MEF2C
url http://link.springer.com/article/10.1186/s12920-019-0558-8
work_keys_str_mv AT kevinyauy disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT anouckschneider disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT beelingng disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT jeanbaptistegaillard disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT satishsati disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT christinecoubes disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT constancewells disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT magalitournaire disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT thomasguignard disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT paulinebouret disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT davidgenevieve disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT jacquespuechberty disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT franckpellestor disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
AT vincentgatinois disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport
_version_ 1724171473207164928
spelling doaj-af431e66ab844436af04e46b042eb9d42021-04-02T07:07:40ZengBMCBMC Medical Genomics1755-87942019-08-011211610.1186/s12920-019-0558-8Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case reportKevin Yauy0Anouck Schneider1Bee Ling Ng2Jean-Baptiste Gaillard3Satish Sati4Christine Coubes5Constance Wells6Magali Tournaire7Thomas Guignard8Pauline Bouret9David Geneviève10Jacques Puechberty11Franck Pellestor12Vincent Gatinois13Unité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierCytometry Core Facility, The Wellcome Trust Sanger InstituteUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierChromatin and Cell Biology Group, CNRS-Institute of Human GeneticsService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierAbstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explored by microarray, Array Painting and Sanger sequencing. No gene disruption was found but the chromosome 5 breakpoint was localized 228-kb upstream of the MEF2C gene. The predicted Topologically Associated Domains analysis shows that it contains only the MEF2C gene and a long non-coding RNA LINC01226. RNA studies looking for MEF2C gene expression revealed an overexpression of MEF2C in the lymphoblastoid cell line of the patient. Conclusions Pathogenicity of MEF2C overexpression is still unclear as only four patients with mild intellectual deficiency carrying 5q14.3 microduplications containing MEF2C are described in the literature. The microduplications in these individuals also contain other genes expressed in the brain. The patient presented the same phenotype as 5q14.3 microduplication patients. We report the first case of a balanced translocation leading to an overexpression of MEF2C similar to a functional duplication.http://link.springer.com/article/10.1186/s12920-019-0558-8Intellectual disability (ID)Topologically associated domains (TAD)MEF2C